{
    "clinical_study": {
        "@rank": "149789", 
        "acronym": "TAP Bloc", 
        "arm_group": [
            {
                "arm_group_label": "Small volume", 
                "arm_group_type": "Experimental", 
                "description": "Local analgesia by one injection of 0,2 ml/kg of  0,2% l\u00e9vobupivacaine"
            }, 
            {
                "arm_group_label": "High volume", 
                "arm_group_type": "Experimental", 
                "description": "Local analgesia by one injection of 0,4 ml/kg of  0,1% l\u00e9vobupivacaine"
            }
        ], 
        "brief_summary": {
            "textblock": "The transversus abdominis plane (TAP) block provide a local anesthesia drug diffusion\n      between the transverse abdominis muscle and the internal oblique muscle. TAP block reaches\n      the anterior rami of spinal nerves from T7 to L1 involved in the innervation of homolateral\n      abdominal wall. The transversus abdominis plane block has shown promise for perioperative\n      analgesia, but data on the optimal dose regimen are limited.Following previous research of\n      optimal dose of local anesthesic solution, the investigators aim to evaluate if a \"volume\n      effect\"  would lead to a better diffusion of the local anesthesic solution to the overall\n      nervous roots. The local anesthesia drug choosen is levobupivacaine with a unique posology\n      of 0,4 mg/kg (either 0,2 ml/kg of 0,2% levobupivacaine for \"small volume\" group or 0,4 ml/kg\n      of 0,1% levobupivacaine for \"high volume\" group).With the same dose of levobupivacaine, this\n      study aims  to assess the impact of volume effect on analgesia efficiency as well as the\n      security as after ultrasound  TAP  block on one to five years' old children who undergo a\n      peritoneal-vaginal duct surgery."
        }, 
        "brief_title": "Transversus Abdominis Plane Block in Pediatrics: Volume or Concentration ?", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Inguinal or Ovarian Hernia", 
            "Hydrocele", 
            "Cord Kyst", 
            "Local Analgesia Block", 
            "One to Five Years"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hernia", 
                "Testicular Hydrocele"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Hospitalisation in ambulatory surgery and anesthesia unit for surgery of inguinal\n             hernia or ovarian hernia or hydrocele or cord kyst\n\n          -  Overall status: ASA I-II\n\n          -  Aged from 1 to 5 years\n\n          -  Informed consent\n\n        Exclusion Criteria:\n\n          -  Coagulation trouble\n\n          -  Infection on ponction zone\n\n          -  Local anesthesia drug or nonsteroidal anti inflammatory intolerance\n\n          -  Cardiac/Renal/hepacticdysfunction\n\n          -  Hemorrage, digestive perforation history"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "5 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02064088", 
            "org_study_id": "UF9206"
        }, 
        "intervention": [
            {
                "arm_group_label": "Small volume", 
                "description": "Ultrasound guided administration of  0,2 ml/kg of  0,2% l\u00e9vobupivacaine in the plane between the internal oblique and transversus abdominis muscles", 
                "intervention_name": "Injection of 0,2 ml/kg of 0,2%  levobupivacaine for small volume group", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "High volume", 
                "description": "Ultrasound guided administration of  0,4 ml/kg of  0,1% l\u00e9vobupivacaine in the plane between the internal oblique and transversus abdominis muscles", 
                "intervention_name": "Injection of 0,4 ml/kg of  0,1% l\u00e9vobupivacaine for high volume group", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Analgesics", 
                "Levobupivacaine", 
                "Bupivacaine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Regional anesthesia", 
            "TAP block", 
            "Pediatric anesthesia", 
            "analgesic effects", 
            "pharmacokinetics"
        ], 
        "lastchanged_date": "February 13, 2014", 
        "location": {
            "contact": {
                "email": "c-sola@chu-montpellier.fr", 
                "last_name": "Chrystelle CS SOLA, MD", 
                "phone": "+33 665849166"
            }, 
            "contact_backup": {
                "email": "s-bringuierbranchereau@chu-montpellier.fr", 
                "last_name": "Sophie SB BRINGUIER-BRANCHEREAU, PhD", 
                "phone": "+33 467338661"
            }, 
            "facility": {
                "address": {
                    "city": "Montpellier", 
                    "country": "France", 
                    "zip": "34925"
                }, 
                "name": "CHU Montpellier"
            }, 
            "investigator": [
                {
                    "last_name": "Chrystelle CS SOLA, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Christophe CD DADURE, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Olivier OR RAUX, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Alain AR ROCHETTE, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Volume or Concentration for the Transverse Abdominal Plane Block in Children Aged 1-5 Years: Analgesic Effects and Safety", 
        "overall_contact": {
            "email": "c-sola@chu-montpellier.fr", 
            "last_name": "Chrystelle CS SOLA, MD", 
            "phone": "+33 665849166"
        }, 
        "overall_contact_backup": {
            "email": "s-bringuierbranchereau@chu-montpellier.fr", 
            "last_name": "Sophie SB BRINGUIER-BRANCHEREAU, PhD", 
            "phone": "+33 467338661"
        }, 
        "overall_official": {
            "affiliation": "CHU Montpellier - Lapeyronie Hospital", 
            "last_name": "Chrystelle CS SOLA, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Committee for the Protection of Personnes", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "number of patients for whom a rescue analgesia was necessary in post anesthesia care unit and ambulatory surgery unit", 
            "safety_issue": "No", 
            "time_frame": "from arrival in post anesthesia care unit until discharge (An expected average of 4 hours after end of surgery)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02064088"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Intraoperative opioid consumption : total R\u00e9mifentanil (\u00b5g/kg)", 
                "safety_issue": "No", 
                "time_frame": "for time of surgery (1 to 4 hours)"
            }, 
            {
                "description": "Post operative pain is evaluated every 15 minutes in the recovery room and then every two hours in the ambulatory surgical unit until discharge at home.", 
                "measure": "Post operative pain (FLACC scale) at hospital", 
                "safety_issue": "No", 
                "time_frame": "from recovery room until discharge (An expected average of 4 hours after end of surgery)"
            }, 
            {
                "measure": "Plasmatique peak of levobupivacaine (Cmax in \u00b5g/ml)", 
                "safety_issue": "Yes", 
                "time_frame": "5 min until 75 min after injection of local anaesthetic"
            }, 
            {
                "measure": "Time necessary to reach plasmatique peak of levobupivacaine (tmax in min)", 
                "safety_issue": "Yes", 
                "time_frame": "5 min until 75 min after injection of local anaesthetic"
            }, 
            {
                "description": "cardiovascular adverse event, adverse vascular ponction (positive aspiration test for blood), adverse peritoneal ponction, hematoma", 
                "measure": "Complications related to local analgesia procedure", 
                "safety_issue": "Yes", 
                "time_frame": "until 24 hours in post operative"
            }, 
            {
                "measure": "First request of rescue antalgic (Nubain or Tramadol)", 
                "safety_issue": "No", 
                "time_frame": "until 24 hours in post operative"
            }, 
            {
                "measure": "Consommation of rescue antalgic", 
                "safety_issue": "No", 
                "time_frame": "until 24 hours in post operative"
            }, 
            {
                "measure": "Pain evaluation at home by parents (score PPMP)", 
                "safety_issue": "No", 
                "time_frame": "call between 24 and 48 hours in post operative"
            }
        ], 
        "source": "University Hospital, Montpellier", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Montpellier", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}